transplants

UCLA has become a world leader in organ transplants, giving hope — and many more years — to patients.

At the new research park, the California Institute for Immunology and Immunotherapy at UCLA is poised to enter a new era of biomedical breakthroughs.

The two grant projects, funded by the National Institutes of Health and the Department of Defense, will be led by Dr. Jerzy Kupiec-Weglinski.

“It was an incredible span and an incredible career,” said Dr. Ronald Busuttil. “I couldn’t be happier.”

Dr. Fady Kaldas has been named the inaugural holder of the Kelly Lee Tarantello Endowed Term Chair in Integrative Liver Transplantation.

Dr. Abbas Ardehali said the success will provide valuable insights for other transplant programs.

Annual event at UCLA commemorates “the remarkable accomplishments of the last year and our patients’ incredible stories of hope and inspiration.”

The study opens the door to research that could determine which bacteria need to be “turned down” to limit their negative effects in transplant patients.

In just 100 years, UCLA has grown into a world-class center of learning, research and health care.

The 641 procedures included kidney, pancreas, lung, heart and intestine transplants. UCLA Health continues to lead this year.

The team performed a staggering 363 kidney transplants in 2017, more than any other transplant center in the United States, according to data.

The process analyzes several possible risk scenarios to help doctors more thoroughly assess people who could be candidates for heart transplants.

“Tissues are wonderfully complex structures, so to engineer artificial versions of them that function properly, we have to recreate their complexity,” said UCLA professor Ali Khademhosseini.

UCLA’s Dr. Jeffrey Veale says that re-donating previously transplanted kidneys after the first recipient dies should be standard practice.

Story of altruistic organ donor acts as tipping point for son’s decision to donate a kidney to his ailing father.

A new UCLA-led study traces how the first three "kidney voucher cases" led to 25 lifesaving kidney transplants across the United States.

Scientists will use the funds in part to develop medications to prevent organ rejection after surgery.

The group’s research will aim to identify new strategies for combating cytomegalovirus, a frequent cause of organ rejection.

In October 2016, Jonathan Koch, a 51-year-old entertainment executive from Los Angeles, underwent a 17-hour procedure to replace the hand he lost to a mysterious, life-threatening illness.

Denice Lombard and her father, Ted, made history in 1967 and now they’re urging others to become organ donors.

The thoracic transplant program also ranks among the country’s best in terms of patient survival rates, according to the Scientific Registry of Transplant Recipients.

Blood donors representing many ethnicities and backgrounds pool precious resource to save woman’s life.

A young woman gets life-saving transplant when a UCLA medical team agrees to take her high-risk case when other transplant centers would not.

Running 13.1 miles may seem like a daunting task to many people. But for heart transplant recipient Tony Flores, it was pure joy to finish the Revel Canyon City Half Marathon in Azusa on Nov. 12.

The UCLA program has become the first program on the West Coast, and one of only seven centers nationwide, to achieve this milestone.